We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma

News   Feb 12, 2008

 
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma
 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Gut Protein Could Prevent Deadly Complication of Bone Marrow Transplant

News

Researchers have discovered that an antimicrobial protein found in the gut can stave off a common and highly lethal side effect of bone marrow transplants.

READ MORE

Cryo-EM Reveals Potential Drug Target for Neurological Conditions

News

A team led by Van Andel Research Institute (VARI) scientists has revealed for the first time the atomic-level structure of TRPM2, a protein that may be a promising drug target for conditions such as Alzheimer's disease and bipolar disorder.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE